Non-ionic contrast agent Pharmacological effects Clinical application Intravascular applications Dosage and Usage Medicine interactions Adverse effects Precautions Uses
ChemicalBook > CAS DataBase List > Iohexol

Iohexol

Non-ionic contrast agent Pharmacological effects Clinical application Intravascular applications Dosage and Usage Medicine interactions Adverse effects Precautions Uses
Product Name
Iohexol
CAS No.
66108-95-0
Chemical Name
Iohexol
Synonyms
Lohexol;NYCODENZ;omnipaque;Iohexal;iohexole;Histodenz;5-(n-dhp-acetamido)-2,4,6-triiodo-n,n’-bis-dhp-isophthalami;5-[Acetyl(2,3-dihydroxypropyl)amino]-N,Nbis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide;5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide;Iohexo
CBNumber
CB2262877
Molecular Formula
C19H26I3N3O9
Formula Weight
821.14
MOL File
66108-95-0.mol
More
Less

Iohexol Property

Melting point:
254-2560C
Boiling point:
891.5±65.0 °C(Predicted)
Density 
1.078 g/mL±0.002 g/mL at 25 °C(lit.)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
Very soluble in water, freely soluble in methanol, practically insoluble in methylene chloride.
pka
11.35±0.46(Predicted)
form 
Solid
color 
White
Merck 
14,5052
BRN 
2406632
Stability:
Hygroscopic
InChIKey
NTHXOOBQLCIOLC-UHFFFAOYSA-N
LogP
-0.5
CAS DataBase Reference
66108-95-0(CAS DataBase Reference)
EPA Substance Registry System
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- (66108-95-0)
More
Less

Safety

Safety Statements 
22-24/25
WGK Germany 
1
RTECS 
CZ2205000
HS Code 
2924296000
Toxicity
LD50 in male, female rats, mice (g Iodine/kg): 15.0, 12.3, 24.3, 25.1 i.v. (Salvesen)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P321Specific treatment (see … on this label).

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
Y0000672
Product name
Iohexol for peak identification
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
10 mg
Price
$156
Updated
2025/07/31
Sigma-Aldrich
Product number
I0320800
Product name
Iohexol
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
150 mg
Price
$236
Updated
2025/07/31
Sigma-Aldrich
Product number
74147
Product name
Iohexol
Purity
analytical standard
Packaging
50mg
Price
$116
Updated
2025/07/31
Sigma-Aldrich
Product number
1344600
Product name
Iohexol
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
550MG
Price
$524
Updated
2025/07/31
Sigma-Aldrich
Product number
1344600
Product name
Iohexol
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
200mg
Price
$445
Updated
2022/05/15
More
Less

Iohexol Chemical Properties,Usage,Production

Non-ionic contrast agent

Iohexol is a non-ionic contrast agent with its pure product appearing as white or light gray powder and having hygroscopicity. In the early 80s of last century, it has been successfully developed by the Nycomed Company (Norwegian) and has first entered into market in 1982 in Norway and Sweden. In 1985, it has obtained the approval of the US Food and Drug Administration (FDA) for entering into US market; in the early 90s, Schering AG and Japan's first pharmaceutical Co., Ltd. were respectively subject to transferee production with product sales in Europe and the Asia-Pacific countries.
The six hydroxyl groups in its molecules are evenly distributed around the benzene ring, effective shielding the lipophilic iodobenzene ring, making it have high hydrophilic, low viscosity, low permeability than ordinary ion-type contrast agent and low toxicity against the nerve system, etc. It is the raw material for the production of water-soluble, non-ionic X-CT contrast agent in pharmaceutical factory. Iohexol is also currently one of the best contrast agents. The developed countries have completely used it to replace ionography agent. It is suitable for myelography, cardiovascular, arteriovenous, lymphatic system, urography and enhanced CT scan. The general dosage is as follows: decision regarding spinal canal imaging is based on the location; lumbar thoracic 24% solution: 8~12ml, neck 24% solution: 10~15ml, CT scan Cisternography 8~12ml.

Pharmacological effects

Iohexol contrast agent belongs to non-ionic water-soluble contrast agent with a similar osmotic pressure with plasma as well as moderate viscosity. It is easily for injection. Clinical angiography and urography have proved less toxic than ionic contrast agents, and can be safely used for myelography. The reason is that the non-ionic contrast agent has weak stimulation on the mast cell with less histamine release and less likely to cause allergic reactions. This product is weak vasodilator, not easy to cause hypotension; it causes very small injury on vascular endothelium, difficult to form thrombosis; small effect on heart and kidney function. It has a lower toxicity than amikacin. This product almost does not penetrate the cell membrane. After intravenous injection, it is mainly distributed in the interstitial cavity without being absorbed by organ and tissue. It is not metabolized by the body and is released mostly with the urine in the prototype form. PBP is smaller than 20%.
Non-ionic intravascular contrast agents: such as iobitridol, ioversol, iodohexol, iopamidol, iopromide and iodixanol.

Clinical application

It can be used for angiography, urography, cerebral angiography, peripheral and various kinds of arterial angiography, venography, digital subtraction and CT enhanced scan. Myelography and the use of subarachnoid injection for brain pool CT scan. It can also be applied to various kinds of body cavity examinations.
Subarachnoid space application
①It should be done of iodine allergy test before the application. Patients of positive result should be disabled. Patients of a history of epilepsy should be disabled.
②Patients having a history of allergies or being suspected allergic to this product, but must be subject to the angiography of this product can choose to apply adrenal cortex hormones and antihistamines before the contrast to prevent. But the spinal cord should be disabled of applying adrenal corticosteroid drugs.
③Patients of local or systemic bacterial infection should not carry out lumbar puncture, of course, can’t use this product for angiography.
④If necessary, it can be given of sedation agents such as diazepam before surgery. Upon severe pain, it can be administrated of analgesics.
⑤Good body fluid condition can reduce the incidence of adverse reactions, therefore it should be prevented of dehydration of patients.
⑥After angiography, allow the patients to sit in bed. The head should be elevated for at least 6 hours. The patient should maintain the supine position for 24 hours without self-move or bending down to prevent the residual contrast agent from flowing into the brain and reduce the leakage of cerebrospinal fluid.
⑦If the patients get nausea, vomiting, it should be applied of intravenous fluids to replace the fluid food; if necessary, it should be given of antiemetic.
⑧Upon myelography failure, it is not appropriate for immediate repeated angiography.
⑨Upon seizures, it should be immediately applied of intravenous injection of 10mg diazepam. To prevent recurrence of epilepsy, it can be applied of intramuscular injection of 0.2 g phenobarbital sodium at 20 to 30 minutes after the stopping of pathogenesis.
⑩The relative density of iohexol injection should be higher than that of cerebrospinal fluid.

Intravascular applications

①Before use, it should be applied of allergy testing. Positive patients should be disabled.
②Patients having a history of allergy, being allergic to iodine, of asthma should be disabled or used with caution.
③Patients of severe liver and kidney dysfunction, severe thyroid disease, bone marrow leukemia should be used with caution; These patients should be disabled upon dehydration. Patients of diabetes having a serum creatinine concentration of more than 0.5mmol /L should be disabled.
④pregnant women should be used with caution. Under conditions that it must be applied, it should be used of the lowest dose.
⑤This product can interfere with thyroid function tests, so that the ability of thyroid tissue  binding to iodine will be reduced, and it should be taken of several days or even two weeks for fully recover.
⑥contrast agent should not be mixed with other drugs for compatibility, instead should be used of a dedicated syringe.

Dosage and Usage

Intrathecal injection: Dose should be according to the check project and the usage technical decisions. It can be referred to the following table.

Application items
Concentration (mg/ml)
Usage amount (ml/per time)
Waist, thoracic
angiography
180
240
0~15
8~12
Cervical angiography
CT scan Cisternography
240
180
240
10~12
5~15
4~12
Myelography for children
 
 
<2 years old
2~6 years old
>6 years old
180
180
180
2~6
4~8
6~12
It can be used for cardiovascular, arterial intravenous and urinary tract radiography. The iodine concentration and dosage used should be generally the same as other angiographic contrast agents currently used.

Medicine interactions

1, Patients subjecting to metformin treatment, if subjecting to simultaneous injection of iohexol contrast agent, may get lactic acidosis and acute renal failure.
2, Simultaneous administration of tricyclic antidepressants or monoamine oxidase inhibitors during the intrathecal injection of the drug can reduce the threshold of seizures, and lead to seizures.
3. Patients treated with interleukin-2 within 2 weeks had an increased risk of delayed response (cold-like symptoms and skin reactions).
4, Ⅲ antiarrhythmic drugs such as amiodarone, in the recommended dose, can extend the QT interval. The effect of prolonging the QT interval when combined with this product has additive effect.
This information was edited by Chemicalbook (2015-08-03).

Adverse effects

1. Adverse effects after application in subarachnoid space are generally the same as that of receiving the lumbar puncture, but are mostly mild. The incidence of headache is less than that of using meglumine. Severe headache lasting several days may be intermittent. Other may have nausea, vomiting, dizziness, neck back pain, limb pain and paresthesia. EEG showed no clear short wave.
2. Adverse effects after intravascular administration were significantly lower than those of other ionic contrast agents in frequency and severity, and adverse reactions were similar to that of meglumine. A small number of patients have mild reactions, such as warm feeling, red, nausea, vomiting, mild chest pain, skin itching, urticaria, numbness and lower limbs.

Precautions

1, Patients with allergic history to iodine and allergic constitution should take with caution.
2, Patients of liver and kidney dysfunction, heart and circulatory system dysfunction, physical weakness, cerebral arteriosclerosis, diabetes, goiter and leukemia should take with caution.
3, Patients of severe hyperthyroidism should be disabled.
4, generally it should be prepared well of acute allergic reactions rescue.
Chemical properties
It appears as white or light gray powder with hygroscopicity.

Uses

It is the raw material for the production of water-soluble, non-ionic X-CT contrast agent in pharmaceutical factory. The trade name of this contrast agent is Omnipaque. This contrast agent is usually injected into the vein before CT angiography to be used for angiography, urinary system, spinal cord and joint, lymphatic system angiography, with advantages of low contrast density, low toxicity and good tolerance type. Iohexol is also currently one of the best contrast agents. The developed countries have completely used it to replace ionography agent. It is also a diagnostic drug.
It can be used as non-ionic X-CT contrast agent.

Chemical Properties

White Solid

Uses

antibacterial

Uses

Imaging agent.

Definition

ChEBI: A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

brand name

Omnipaque (GE Healthcare).

General Description

Iohexol is a low-osmolar, nonionicmonomer with 46% iodine content. Iohexol is one ofthe few iodinated contrast agents indicated for intrathecaluse (myelography). Only selected concentrations of theproduct have this indication. Besides myelography, iohexolfinds widespread use in excretory urography, angiography,and CT procedures. Specific concentrations may have additionalindications in adults and/or children for arthrography,hysterosalpingography, endoscopic retrograde pancreatography,cholangiopancreatography, herniography, voidingcystourethrography, oral pass-thru examination of the GItract or CT of the abdomen.

Synthesis

31127-80-7

106-89-8

66108-95-0

92339-11-2

N1,N3-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodomethylbenzene dicarboxamide (Compound A, 1120.5 kg, 1.50 kmol) and 1-chloro-2,3-propylene oxide were synthesized as 5-(acetamido)-N,N'-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6- Triiodo-m-toluene dicarboxamide and 5,5'-((2-hydroxypropyl-1,3-diyl)bis(acetylazanediyl))bis(N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-m-toluene dicarboxamide) in the following general steps: 1. dissolve compound A (1120.5 kg, 1.50 kmol) in a solution of water (1232.6 kg) containing KOH (140.0 kg, 2.25 kmol), controlling the temperature below 20 °C. 2. boric acid (64.9 kg, 1.05 kmol) and hydrochloric acid (30.4 kg, 0.30 kmol) were added in batches. 3. 1-chloro-2,3-epoxypropane (83.3 kg, 0.90 kmol) was added slowly and dropwise, keeping the pH of the reaction system between 10-11. 4. The progress of the reaction was monitored by HPLC during the reaction. 5. When the content of compound A was below 5%, the reaction was quenched by addition of water (1232.6 kg) and the pH was adjusted to 5-6 with 18% hydrochloric acid. 6. The reaction mixture was decolorized by activated carbon and filtered. 7. HPLC analysis showed that the filtrate contained 86.3% iodixanol, 7.5% iodohexanol, 2.9% compound A and 2.7% O-alkylation by-products and other impurities.

References

[1] Patent: WO2011/63551, 2011, A1. Location in patent: Page/Page column 15-16
[2] Patent: EP2277853, 2011, A1. Location in patent: Page/Page column 7
[3] Patent: EP2277852, 2011, A1. Location in patent: Page/Page column 7
[4] Acta Chemica Scandinavica, 1995, vol. 49, # 6, p. 446 - 456
[5] Patent: US2011/21823, 2011, A1. Location in patent: Page/Page column 2-3

Iohexol Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Iohexol Suppliers

Hefei TNJ Chemical Industry Co.,Ltd.
Tel
551-65418679 15837135945
Fax
0551-65418697
Email
info@tnjchem.com
Country
China
ProdList
1889
Advantage
62
Wuhan Dingtong Pharmaceutical Co., Ltd
Tel
027-027-59207795 18327179646
Fax
027-59207795
Email
18327179646@163.com
Country
China
ProdList
1986
Advantage
58
ZHEJIANG HICHIPHARMACEUTICALCORPORATION LIMITED
Tel
13958554356 15715702293
Email
sales@hichipharm.com
Country
China
ProdList
11
Advantage
58
Hubei Kailong Biotechnology Co.,Ltd.
Tel
19526384105
Email
3671394075@qq.com
Country
China
ProdList
2864
Advantage
58
Hubei Yanke Times Technology Co., Ltd
Tel
15780669880 15727070860
Email
15780669880@163.com
Country
China
ProdList
997
Advantage
58
Shanghai Amole Biotechnology Co., Ltd.
Tel
18916360931 18916360931
Email
2596183085@qq.com
Country
China
ProdList
9309
Advantage
58
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15838
Advantage
69
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Fax
021-67121385
Email
Sales-CN@TCIchemicals.com
Country
China
ProdList
24529
Advantage
81
Beijing HwrkChemical Technology Co., Ltd
Tel
18515581800 18501085097
Fax
010-89508210
Email
sales.bj@hwrkchemical.com
Country
China
ProdList
9400
Advantage
55
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
16075
Advantage
64
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Country
China
ProdList
42934
Advantage
64
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32321
Advantage
50
XiaoGan ShenYuan ChemPharm co,ltd
Tel
15527768836
Email
1791901229@qq.com
Country
China
ProdList
6950
Advantage
52
Sinopharm Chemical Reagent Co,Ltd.
Tel
86-21-63210123
Fax
86-21-63290778 86-21-63218885
Email
sj_scrc@sinopharm.com
Country
China
ProdList
9815
Advantage
79
Hunan Hui Bai Shi Biotechnology Co., Ltd.
Tel
0731-85526065 13308475853
Email
ivy@hnhbsj.com
Country
China
ProdList
7247
Advantage
62
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Country
China
ProdList
4747
Advantage
58
ShangHai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847 13636370518
Fax
021-55068248
Email
shyysw007@163.com
Country
China
ProdList
4999
Advantage
60
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12335
Advantage
58
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-6206333 13167063860
Fax
021-50323701
Email
anhua.mao@aladdin-e.com
Country
China
ProdList
25003
Advantage
65
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
TargetMol Chemicals Inc.
Tel
021-021-33632979 15002134094
Fax
021-33632979
Email
marketing@targetmol.com
Country
China
ProdList
7782
Advantage
58
Hubei XinyuanShun Chemical Co., Ltd.
Tel
13971561712, 13995564702, 027-50664929
Fax
027-50664927
Email
hbeixys2001@163.com
Country
China
ProdList
3120
Advantage
55
Shanghai JONLN Reagent Co., Ltd.
Tel
400-0066400 13621662912
Fax
021-55660885
Email
422131432@qq.com
Country
China
ProdList
9979
Advantage
55
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Fax
+86-21-61629029
Email
product02@bidepharm.com
Country
China
ProdList
39966
Advantage
60
Chemwill Asia Co.,Ltd.
Tel
86-21-51086038
Fax
86-21-51861608
Country
China
ProdList
2930
Advantage
58
Mei Lan Industrial (Shanghai) Co., Ltd.
Tel
021-58958189
Fax
021-58957967
Email
wouchina@126.com
Country
China
ProdList
2666
Advantage
55
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
18333
Advantage
56
Shanghai ideal Industrial Co., Ltd.
Tel
021-58957966 18930537195
Fax
021-60899437
Email
wouchina@126.com
Country
China
ProdList
3027
Advantage
58
GuangTuo Chemical (Shanghai) Co., Ltd.
Tel
021-60899189-8001 18918189673
Fax
021-60899304
Email
gtchem@126.com
Country
China
ProdList
2656
Advantage
58
Chengdu Laurelsci Tech Co., Ltd.
Tel
028-87983001
Fax
+86-28-86102331
Email
sales@laurelsci.com
Country
China
ProdList
50
Advantage
58
Wuhan Dahua Pharmaceutical Co., Ltd.
Tel
027-59262863 13277907145 3091977954
Fax
027-59420980
Country
China
ProdList
4942
Advantage
58
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939
Fax
021-50706099
Email
shenlinxing@macklin.cn
Country
China
ProdList
15873
Advantage
55
Shanghai Kewel Chemical Co., Ltd.
Tel
021-64609169 18901607656
Fax
021-64609160
Email
greensnown@163.com
Country
China
ProdList
9906
Advantage
50
Hangzhou J&H Chemical Co., Ltd.
Tel
0571-87396432
Fax
0571-87396431
Email
sales@jhechem.com
Country
China
ProdList
14912
Advantage
59
Wuhan Dahua Weiye Pharmaceutical Chemical Co., Ltd.
Tel
027-59420981,18702770802
Fax
027-83322098
Country
China
ProdList
1975
Advantage
50
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
Fax
+86 (21) 6129-4103
Country
China
ProdList
9756
Advantage
58
Chizhou Kailong Import and Export Trade Co., Ltd.
Tel
Fax
-
Email
xg01_gj@163.com
Country
China
ProdList
9484
Advantage
50
Beijing NuoqiYa Biotechnology Co., Ltd.
Tel
4000-819-385 010-62329685 13718666987
Fax
010-62340519
Country
China
ProdList
1971
Advantage
55
Hangzhou Dingyan Chem Co., LTD
Tel
0571-87157530-8008 17369838938
Fax
0571-87156470
Email
sales@dingyanchem.com
Country
China
ProdList
2386
Advantage
58
ShangHai Siyan Biological Technology Co., Ltd.
Tel
021-50908862,442785678,326799392 18721037013
Fax
021-50908862
Email
siyansales@126.com
Country
China
ProdList
9627
Advantage
58
Shanghai Haozhixiang Biotechnology Co., Ltd
Tel
526763801 13301653310
Fax
+86-21-51619052
Email
526763801@qq.com
Country
China
ProdList
9279
Advantage
55
Henan CoreyChem Co., Ltd
Tel
0371-86658258
Fax
0371-60996044
Email
info@coreychem.com
Country
China
ProdList
10453
Advantage
58
Artis Biotech Co. Ltd.
Tel
028-67271278 18628360895
Fax
0575-89298961
Email
sales@artisbio.com
Country
China
ProdList
1960
Advantage
58
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3866
Advantage
58
Chengdu HuaNa Chemicals Co., Ltd.
Tel
028-86612776; 13699069380
Fax
-
Email
515238037@qq.com
Country
China
ProdList
968
Advantage
55
Shandong Xiya Chemical Co., Ltd.
Tel
4009903999 13395398332
Fax
0539-6365991
Email
sales@xiyashiji.com
Country
China
ProdList
20794
Advantage
60
Raw material medicin reagent co.,Ltd
Tel
Email
sales@njromanme.com
Country
China
ProdList
4529
Advantage
58
Chengdu Huachun Technology Co., Ltd
Tel
400-1166-196 15982826727
Fax
QQ:800101999
Email
cdhxsj@163.com
Country
China
ProdList
14603
Advantage
60
More
Less

View Lastest Price from Iohexol manufacturers

Shaanxi Dideu New Materials Co. Ltd
Product
Iohexol 66108-95-0
Price
US $0.00/kg
Min. Order
1kg
Purity
98%
Supply Ability
1000kg
Release date
2025-09-29
Wuhan JiyunZen Tech Co., Ltd.
Product
Iodixanol 66108-95-0
Price
US $5.00-0.50/KG
Min. Order
1KG
Purity
99% hplc
Supply Ability
500TONS
Release date
2025-05-07
WUHAN FORTUNA CHEMICAL CO., LTD
Product
Iohexol 66108-95-0
Price
US $0.00/KG
Min. Order
1KG
Purity
98%
Supply Ability
2000kg/month
Release date
2021-06-23

66108-95-0, IohexolRelated Search:


  • IOHEXOL
  • 5-(N-2,3-DIHYDROXYPROPYLACETAMIDO)-2,4,6-TRIIODO-N,N'-BIS(2,3-DIHYDROXYPROPYL)ISOPHTHALAMIDE
  • 5-(N-2-3-DIHYDROXYPROPYL-ACETMIDO)-2,4,6-TRIIODO-N,N'-BIS-(2,3-DIHYDROXYPROPYL)-ISOPHTHALAMIDE
  • NYCODENZ
  • N,N'-BIS(2,3-DIHYDROXYPROPYL)-5-[N-(2,3-DIHYDROXYPROPYL)ACETAMIDO]-2,4,6-TRIIODOISOPHTHALAMIDE
  • 1,3-benzenedicarboxamide,5-(acetyl(2,3-dihydroxypropyl)amino)-n,n’-bis(2,3-dih
  • 5-(n-dhp-acetamido)-2,4,6-triiodo-n,n’-bis-dhp-isophthalami
  • 6-triiodo-ydroxypropyl)-4
  • exypaque
  • omnipaque
  • omnipaque240
  • win39424
  • 5-[Acetyl(2,3-dihydroxypropyl)amino]-N,Nbis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
  • Accudenz
  • Omnipaque 140
  • Omnipaque 300
  • Omnipaque 350
  • Omnipaque R
  • 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
  • iohexole
  • 5-(N-2,3-dihydroxypropylacetamido)-*2,4,6-triiodo
  • 5-[N-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N-bis(2,3-dihydroxypropyl)isophthalamide solution
  • histodenz solution
  • Lohexol
  • HISTODENZ(TM)
  • IODOMETHYLSULBACTAN
  • Nycodenz(R), 5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,Nμ-bis(2,3-dihydroxypropyl)isophthalamide
  • N,Nμ-Bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide, 5-[N-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,Nμ-bis(2,3-dihydroxypropyl)isophthalamide solution
  • 5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N-bis-(2,3 dihydroxypropy)isophthaamide
  • Histodenz
  • 5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
  • 5-[acetyl(glyceryl)amino]-N,N'-diglyceryl-2,4,6-triiodo-isophthalamide
  • N1,N3-bis(2,3-dihydroxypropyl)-5-[2,3-dihydroxypropyl(ethanoyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
  • Histodenz,5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N′-bis(2,3-dihydroxypropyl)isophthalamide, Nycodenz
  • Iohexol (200 mg)
  • 1-N,3-N-bis[(2S)-2,3-dihydroxypropyl]-5-{N-[(2S)-2,3-dihydroxypropyl]acetaMido}-2,4,6-triiodobenzene-1,3-dicarboxaMide
  • Iohexol,iohexole,nycodenz,oMnipaque
  • Iohexol COS
  • Iohexal
  • 5-[N-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N′-bis(2,3-dihydroxypropyl)isophthalamide solution
  • 5-(acetyl-(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
  • 5-(acetyl-(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
  • 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
  • bis(2,3
  • N,N'-bis(2,3-dihydroxypropyl)-5-(2,3-dihydroxypropyl-ethanoyl-amino)-2,4,6-triiodo-benzene-1,3-dicarboxamide
  • N1,N3-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide
  • Iohexol (mixture of isomers)
  • 5-<WBR>(N-<WBR>2,3-<WBR>Dihydroxypropylacetamido)<WBR>-<WBR>2,4,6-<WBR>triiodo-<WBR>N,N′-bis(2,3-dihydroxypropyl)isophthalamide
  • Iohexolum
  • Iodixanol Impurity 1(Iodixanol EP Impurity A)
  • Iohexol CAS NO.66108-95-0 CAS NO.66108-95-0
  • Iohexol for peak identification CRS
  • Iohexol CRS
  • Iohexol, isomer mixture
  • Iohexol (mixture of isomers) &gt
  • 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
  • Iohexol (mixture of isomers) [for iTOMEI]
  • Iohexol for peak identification (Y0000672)Q: What is Iohexol for peak identification (Y0000672) Q: What is the CAS Number of Iohexol for peak identification (Y0000672)